Work

Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer and Eye Metastasis: Disease Relapse or a New Entity?

Year: 2016

Type: article

Abstract: Lung cancer is still diagnosed during the advanced stage of the disease and most patients do not have the opportunity for surgical treatment, despite the new diagnostic equipment that has been made available in recent years, such as the radial and linear endobronchial ultrasound (EBUS) and electromagnetic fiberoptic bronchoscopy. However, novel targeted therapies with second generation tyrosine kinase inhibitors and immunotherapy are available. In this commentary, we will focus on eye metastasis after initiation of tyrosine kinase inhibitors due to epidermal growth factor mutation of lung cancer adenocarcinoma.

Source: Medical Hypothesis Discovery & Innovation in Ophthalmology

Authors: Paul Zarogoulidis, Sofia Lampaki, Panos Chinelis, George Lazaridis, Sofia Baka, Aggeliki Rapti

Institutions: Aristotle University of Thessaloniki, G. Papanikolaou General Hospital, Papageorgiou General Hospital, Interbalkan Medical Center, Sotiria General Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W3024353531

FWCI:

Cites: 30

Cited by: 4

Related to: 10